Try Ask OE! Our NEW Advanced AI Enabled Search

Dive into the Largest Database of
Musculoskeletal Evidence

ACE Reports.

ACE Report Image

Metabolic Disorders
Changes in lumbar spine QCT, DXA, and TBS following treatment with denosumab (DMAB), alendronate (ALN), or placebo (PBO) in postmenopausal women with low bone mass

ACE Report Image

Metabolic Disorders
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
N Engl J Med. 2007 Nov 15;357(20):2028-39

Start your FREE trial today!

Your account will be affiliated with
and includes free access to OrthoEvidence

Email

Password

Confirm Password

OR

Already have an account? Login now
Part of an association? Click here you may have full access!

Forgot Password?

Email

OR

Don't have an account? Sign up

Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Help us Improve

Inaccurate Insufficient details Did not answer the question Outdated information Missing important information

Accurate Actionable Complete Answer Helpful References

Provide additional feedback (optional)

Submit Feedback

Thank You!

Thank you for providing valuable feedback regarding your recent interaction with Ask OE.

Return to Ask OE